Russia Coronavirus Vaccine

Total 56
Russia Coronavirus Vaccine

Participants attend a press conference at Sechenov University, after the discharge of the first group of 18 volunteers participating in the COVID-19 vaccine trial, in Moscow, Russia. In the background, from left to right: Director of the Sechenov Universal Antibody Clinical Center, Sergey Semitko; Director of the Institute of Pharmacy and Translational Medicine of Sechenov University, Vadim Tarasov; head of the Center for the Clinical Study of Medicines of Sechenov University, Elena Smolyarchuk; and discharged volunteers. The volunteers were vaccinated on June 18, 2020. Before their discharge, they were in the Scientific and Practical Center for Interventional Cardioangiology of Sechenov University under the supervision of doctors and scientists.

#6286666
Russia Coronavirus Vaccine

Participants attend a press conference at Sechenov University, after the discharge of the first group of 18 volunteers participating in the COVID-19 vaccine trial, in Moscow, Russia. In the background, from left to right: Director of the Sechenov Universal Antibody Clinical Center, Sergey Semitko; Director of the Institute of Pharmacy and Translational Medicine of Sechenov University, Vadim Tarasov; head of the Center for the Clinical Study of Medicines of Sechenov University, Elena Smolyarchuk; and discharged volunteers. The volunteers were vaccinated on June 18, 2020. Before their discharge, they were in the Scientific and Practical Center for Interventional Cardioangiology of Sechenov University under the supervision of doctors and scientists.

#6286656
Russia Coronavirus Vaccine

A director of the Institute of pharmacy and translational medicine of Sechenov University, Vadim Tarasov, and Head of the center for a clinical study of medicines of Sechenov University Elena Smolyarchuk, speak to the media during a press conference at Sechenov University, in Moscow, Russia. The volunteers were vaccinated on June 18, 2020, and until their discharge on July 15, they were in the Scientific and Practical Center for interventional Cardioangiology of Sechenov University under the supervision of doctors and scientists.

#6286655
Russia Coronavirus Vaccine

Participants attend a press conference at Sechenov University, after the discharge of the first group of 18 volunteers participating in the COVID-19 vaccine trial, in Moscow, Russia. In the background, from left to right: Director of the Sechenov Universal Antibody Clinical Center, Sergey Semitko; Director of the Institute of Pharmacy and Translational Medicine of Sechenov University, Vadim Tarasov; head of the Center for the Clinical Study of Medicines of Sechenov University, Elena Smolyarchuk; and discharged volunteers. The volunteers were vaccinated on June 18, 2020. Before their discharge, they were in the Scientific and Practical Center for Interventional Cardioangiology of Sechenov University under the supervision of doctors and scientists.

#6286646
Russia Coronavirus Vaccine

Participants attend a press conference at Sechenov University, after the discharge of the first group of 18 volunteers participating in the COVID-19 vaccine trial, in Moscow, Russia. In the background, from left to right: Director of the Sechenov Universal Antibody Clinical Center, Sergey Semitko; Director of the Institute of Pharmacy and Translational Medicine of Sechenov University, Vadim Tarasov; head of the Center for the Clinical Study of Medicines of Sechenov University, Elena Smolyarchuk; and discharged volunteers. The volunteers were vaccinated on June 18, 2020. Before their discharge, they were in the Scientific and Practical Center for Interventional Cardioangiology of Sechenov University under the supervision of doctors and scientists.

#6286645